Central Pacific Bank Trust Division has disclosed a 1.5% increase in its CVS Health holdings, adding 500 shares during the second quarter. This move, revealed in the latest SEC filing, brings the institutional investor’s total position to 33,000 shares of the pharmacy giant.

Hancock Whitney Corp has trimmed its holdings in CVS Health Corporation by 3.5% in the first quarter, selling 314 shares to bring its remaining total to 8,609. This change, as reported by HoldingsChannel.com, values the investment at $583,000.

After a strong rebound in early 2025, CVS Health’s stock offers an attractive 4% dividend yield. However, regulatory challenges and declining segments cast doubt on its future prospects. Should investors seize the opportunity or proceed with caution?